标题
Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma
作者
关键词
-
出版物
LEUKEMIA
Volume 29, Issue 9, Pages 1918-1927
出版商
Springer Nature
发表日期
2015-03-24
DOI
10.1038/leu.2015.83
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies
- (2014) L. Lopez-Corral et al. HAEMATOLOGICA
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- New directions in ER stress-induced cell death
- (2013) Susan E. Logue et al. APOPTOSIS
- PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma
- (2013) P. G. Richardson et al. BLOOD
- HDAC4 protects cells from ER stress induced apoptosis through interaction with ATF4
- (2013) Pengfei Zhang et al. CELLULAR SIGNALLING
- New Strategies in the Treatment of Multiple Myeloma
- (2013) N. C. Munshi et al. CLINICAL CANCER RESEARCH
- Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
- (2013) Meletios Dimopoulos et al. LANCET ONCOLOGY
- Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs
- (2013) D Cirstea et al. LEUKEMIA
- HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress
- (2013) Nirmalya Sen et al. MOLECULAR CELL
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- (2013) Mercedes Lobera et al. Nature Chemical Biology
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Blockade of XBP1 splicing by inhibition of IRE1 is a promising therapeutic option in multiple myeloma
- (2012) N. Mimura et al. BLOOD
- A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma
- (2011) S. J. Harrison et al. BLOOD
- Peroxisome proliferator-activated receptor γ is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress
- (2011) Yang Yang et al. JOURNAL OF NEUROCHEMISTRY
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
- (2011) Ira Tabas et al. NATURE CELL BIOLOGY
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
- (2010) Daniel Antunes Moreno et al. BRITISH JOURNAL OF HAEMATOLOGY
- HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth
- (2010) T. Milde et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase 9 (HDAC9) Regulates the Functions of the ATDC (TRIM29) Protein
- (2010) Zhigang Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biologic sequelae of I B kinase (IKK) inhibition in multiple myeloma: therapeutic implications
- (2009) T. Hideshima et al. BLOOD
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
- (2008) Peter Gimsing et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now